Sab Biotherapeutics Stock Forecast

Sell candidate since May 27, 2026 Loss -6.11%

The SAB Biotherapeutics, Inc. stock price gained 2.11% on the last trading day (Thursday, 11th Jun 2026), rising from $3.31 to $3.38. During the last trading day the stock fluctuated 3.03% from a day low at $3.30 to a day high of $3.40. The price has been going up and down for this period, and there has been a -5.32% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 26 thousand more shares were traded than the day before. In total, 239 thousand shares were bought and sold for approximately $807.96 thousand.

The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $3.30 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -11.14% during the next 3 months and, with a 90% probability hold a price between $2.93 and $3.62 at the end of this 3-month period.

SABS Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, June 10, 2026, and so far it has risen 2.11%. Further rise is indicated until a new top pivot has been found. SAB Biotherapeutics, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The SAB Biotherapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.38 and $3.63. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for SAB Biotherapeutics, Inc. stock

SAB Biotherapeutics, Inc. finds support from accumulated volume at $3.36 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.100 between high and low, or 3.03%. For the last week, the stock has had daily average volatility of 4.17%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (SABS) For The Upcoming Trading Day Of Friday 12th

For the upcoming trading day on Friday, 12th we expect SAB Biotherapeutics, Inc. to open at $3.36, and during the day (based on 14 day Average True Range), to move between $3.27 and $3.49, which gives a possible trading interval of +/-$0.215 (+/-6.56%) up or down from last closing price. If SAB Biotherapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 6.56% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.36 (0.59%) than the resistance at $3.70 (9.47%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is SAB Biotherapeutics, Inc. stock A Buy?

SAB Biotherapeutics, Inc. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.829 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 12, 2026 - $3.36 ( 0.592%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk